Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

ADMA Biologics Sees FY2025 Sales $500.000M-$625.000M vs $507.67M Est

Author: Benzinga Newsdesk | August 06, 2025 03:43pm

ADMA Biologics (NASDAQ:ADMA) sees FY2025 sales of $500.000 million-$625.000 million vs $507.67 million analyst estimate.

Posted In: ADMA